INTRODUCTION
The aim of the present study was to determine the influence of progesterone on ovarian proteolytic enzyme activity during the process of ovulation in rats. The proteolytic activity was measured after rats were treated with an ovulation-inhibiting dose of 1 7 3-hydroxy-1 1 3-(4-dimethylamino-phenyl-1)-17a-(propynyl-1)-estra-4,9-diene-3-one (RU 
MATERIALS AND METHODS

Ovi.dation Induction
Statistical Analysis
All data are presented as means ± SEM. 
RESULTS
Inhibition of Ovulation by RU486
The ovulation rate in the control group was 36.5 ± 2.0 ova/rat. This was significantly lower when RU486 (10 mg/ kg) was administered at 2 h before, or 0, 2, or 4 h after hCG, but not at 4 h before, or 6, 8, or 10 h after, hCG (Fig.   1 ). 
Effect of RU486 on Serum Progesterone and Estradiol Levels
In untreated controls, serum progesterone levels rose significantly within 6 h after hCG, reached a peak at 8 h, and then declined slightly by 12 h (Fig. 3) 
Effect of RU486 on Ovarian BANA Hydrolase Activity
In controls, BANA hydrolase activity increased significandy at 7 h after hCG and reached a peak at 8-9 h (Fig.  4) (Fig. 4) . Progesterone treatment at 2 or 6 h (but not at 0, 7, or 8 h) after hCG also led to the recovery of BANA hydrolase activity when the activity was measured at 9 h after hCG (Fig. 5) .
Effect of RU486
on Ovarian 
DNP Peptidase Activity
The effect of RU486 (10 mg/kg at 0 h) on DNP peptidase activity was similar to the action of this drug on BANA hydrolase activity, except that at 12 h after hCG the ovarian enzyme activity in the RU486-treated group was significantly higher than in the control group (Fig. 6) . As with BANA hydrolase activity, the optimum time to administer progesterone to reverse the inhibitory action of RU486 on DNP peptidase activity (measured at 9 h after hCG) was 4-6 h after hCG (Fig. 7) .
of inhibition in the time-course Study when epostane is given at 3 h, 6 h, or 7 h after hCG [20, 21] 
